Yasuaki Harasaki, MD
Neurological Surgery · Aurora, CONPI 1538206883
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $70,985 of the $75,116 with a category attached, or 94.5%. Globus Medical accounts for 98.4% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $20,227, 5.5 times the $3,677 reported in 2019.
Across 71 payments — averaging $1057.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$74K
- Cerapedics Inc.$565
- Medtronic$182
- Si-bone, Inc.$129
- Zimmer Biomet$125
- AbbVie$93
- plus $124 from 6 others
What the payments were for
- Royalty or licence$70,98595%
- Consulting fees$2000%
- Speaking & faculty fees$5001%
- Travel & lodging$1,5922%
- Food & beverage$1,7742%
- Education$650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 46 | $73,899 |
| Cerapedics Inc. | 7 | $565 |
| Medtronic(2 entities) | 4 | $182 |
| Si-bone, Inc. | 3 | $129 |
| Zimmer Biomet | 2 | $125 |
| AbbVie | 3 | $93 |
| Mid-atlantic Surgical Systems, LLC | 1 | $33 |
| Avion Pharmaceuticals | 1 | $25 |
| AstraZeneca | 1 | $22 |
| Solventum Corporation | 1 | $18 |
| Portola Pharmaceuticals, LLC | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SI-LOK Select$44,301
- SI-LOK$26,885
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$1,500
- CALIBER$1,235
- Quartex$462
- Excelsius Deformity$142
- CREO$124
- iFuse Implant$107
How this compares
$75,116 in reported general payments places this provider in the 85th percentile of 149 neurological surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 242 | $1,995 |
| Pregabalin | 99 | $1,473 |
| Tizanidine Hcl | 25 | $178 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $92 |
| Tramadol Hcl | 29 | $82 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $59 |
| Diazepam | 13 | $7 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Aurora
- Peter FecciAurora$170K
- Joshua SeinfeldAurora$118K
- David CaseAurora$106K
- Ashraf YoussefAurora$95K
- Allen WaziriAurora$86K
- John SampsonAurora$78K
- Steven OjemannAurora$59K
- Tareq YaseenAurora$37K
- Ahmed HelalAurora$37K
- Fabio GrassiaAurora$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.